Institutional owners may take dramatic actions as Kendrion N.V.’s (AMS:KENDR) recent 13% drop adds to one-year losses

  • Given the large stake in the stock by institutions, Kendrion’s stock price might be vulnerable to their trading decisions

  • The top 5 shareholders own 50% of the company

  • Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

If you want to know who really controls Kendrion N.V. (AMS:KENDR), then you’ll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 59% to be precise, is…

Source link